### Instruction: What is the sentiment of this tweet? Please choose an answer from {negative/neutral/positive} ### Human: After the reporting period , BioTie North American licensing partner Somaxon Pharmaceuticals announced positive results with nalmefene in a pilot Phase 2 clinical trial for smoking cessation . ### Assistant: positive.